Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 74 | 2024 | 8717 | 4.770 |
Why?
|
Mental Recall | 30 | 2020 | 1218 | 4.030 |
Why?
|
Memory Disorders | 23 | 2024 | 1193 | 3.460 |
Why?
|
Evoked Potentials | 18 | 2024 | 1050 | 3.010 |
Why?
|
Neuropsychological Tests | 59 | 2024 | 7119 | 2.710 |
Why?
|
Memory | 26 | 2022 | 2192 | 2.600 |
Why?
|
Verbal Learning | 8 | 2018 | 459 | 1.960 |
Why?
|
Brain Injury, Chronic | 6 | 2019 | 68 | 1.350 |
Why?
|
Pattern Recognition, Visual | 10 | 2012 | 820 | 1.140 |
Why?
|
Consciousness | 2 | 2023 | 602 | 1.120 |
Why?
|
Frontal Lobe | 9 | 2018 | 1408 | 1.010 |
Why?
|
Repression, Psychology | 3 | 2018 | 46 | 0.890 |
Why?
|
Photic Stimulation | 22 | 2017 | 1989 | 0.880 |
Why?
|
Visual Perception | 9 | 2015 | 1392 | 0.840 |
Why?
|
Music | 2 | 2018 | 248 | 0.830 |
Why?
|
Dementia | 6 | 2024 | 2741 | 0.820 |
Why?
|
Semantics | 9 | 2007 | 609 | 0.800 |
Why?
|
Loneliness | 1 | 2024 | 211 | 0.790 |
Why?
|
Electroencephalography | 15 | 2024 | 6282 | 0.770 |
Why?
|
Social Isolation | 1 | 2024 | 366 | 0.760 |
Why?
|
Attention | 12 | 2018 | 2413 | 0.740 |
Why?
|
Aged, 80 and over | 60 | 2024 | 59550 | 0.730 |
Why?
|
Analysis of Variance | 23 | 2017 | 6214 | 0.720 |
Why?
|
Aging | 14 | 2021 | 8731 | 0.690 |
Why?
|
Parietal Lobe | 6 | 2008 | 859 | 0.680 |
Why?
|
Cognition Disorders | 10 | 2018 | 3967 | 0.660 |
Why?
|
Memory, Short-Term | 6 | 2017 | 1004 | 0.620 |
Why?
|
Judgment | 5 | 2009 | 270 | 0.610 |
Why?
|
Reference Values | 14 | 2018 | 4913 | 0.610 |
Why?
|
Imagination | 4 | 2022 | 213 | 0.600 |
Why?
|
Emotions | 8 | 2018 | 2758 | 0.600 |
Why?
|
Brain | 23 | 2024 | 27159 | 0.590 |
Why?
|
Aged | 85 | 2024 | 171343 | 0.580 |
Why?
|
Word Association Tests | 4 | 2006 | 49 | 0.560 |
Why?
|
Feedback | 2 | 2020 | 797 | 0.540 |
Why?
|
Cognition | 15 | 2024 | 7057 | 0.530 |
Why?
|
Neurodegenerative Diseases | 3 | 2024 | 1089 | 0.490 |
Why?
|
Cues | 4 | 2022 | 877 | 0.450 |
Why?
|
Humans | 140 | 2024 | 766766 | 0.450 |
Why?
|
Music Therapy | 2 | 2012 | 111 | 0.440 |
Why?
|
Reaction Time | 13 | 2016 | 2085 | 0.440 |
Why?
|
Male | 96 | 2024 | 364142 | 0.430 |
Why?
|
Matched-Pair Analysis | 7 | 2011 | 285 | 0.420 |
Why?
|
Amyloid beta-Peptides | 11 | 2024 | 3887 | 0.420 |
Why?
|
Child of Impaired Parents | 2 | 2006 | 462 | 0.400 |
Why?
|
tau Proteins | 10 | 2024 | 2107 | 0.400 |
Why?
|
Color Perception | 4 | 2008 | 211 | 0.400 |
Why?
|
Female | 93 | 2024 | 396520 | 0.400 |
Why?
|
Athletic Injuries | 3 | 2019 | 1244 | 0.390 |
Why?
|
Students, Medical | 2 | 2022 | 1962 | 0.380 |
Why?
|
Cholinesterase Inhibitors | 2 | 2011 | 242 | 0.380 |
Why?
|
Amnesia | 4 | 2012 | 257 | 0.380 |
Why?
|
Agnosia | 2 | 2011 | 67 | 0.370 |
Why?
|
Galantamine | 1 | 2011 | 33 | 0.360 |
Why?
|
Diffusion Tensor Imaging | 4 | 2023 | 2418 | 0.360 |
Why?
|
Smiling | 1 | 2011 | 71 | 0.360 |
Why?
|
Choice Behavior | 2 | 2007 | 846 | 0.350 |
Why?
|
Migraine Disorders | 1 | 2023 | 1710 | 0.350 |
Why?
|
TDP-43 Proteinopathies | 1 | 2010 | 40 | 0.350 |
Why?
|
Indans | 1 | 2011 | 92 | 0.350 |
Why?
|
September 11 Terrorist Attacks | 2 | 2009 | 107 | 0.350 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6550 | 0.350 |
Why?
|
Perceptual Disorders | 2 | 2003 | 199 | 0.340 |
Why?
|
Motor Neuron Disease | 1 | 2010 | 98 | 0.340 |
Why?
|
Case-Control Studies | 18 | 2020 | 22248 | 0.330 |
Why?
|
Awareness | 2 | 2011 | 653 | 0.320 |
Why?
|
Reading | 5 | 2012 | 540 | 0.310 |
Why?
|
Learning | 1 | 2018 | 1754 | 0.310 |
Why?
|
Event-Related Potentials, P300 | 3 | 2005 | 149 | 0.300 |
Why?
|
Vocabulary | 2 | 2008 | 166 | 0.300 |
Why?
|
Mental Status Schedule | 5 | 2014 | 315 | 0.300 |
Why?
|
Decision Making | 6 | 2023 | 3951 | 0.300 |
Why?
|
Nootropic Agents | 2 | 2016 | 159 | 0.300 |
Why?
|
Brain Mapping | 13 | 2017 | 6596 | 0.280 |
Why?
|
Contingent Negative Variation | 1 | 2007 | 35 | 0.280 |
Why?
|
Tauopathies | 3 | 2021 | 325 | 0.280 |
Why?
|
Middle Aged | 48 | 2024 | 223257 | 0.270 |
Why?
|
Sensation Disorders | 1 | 2006 | 160 | 0.250 |
Why?
|
Comprehension | 1 | 2011 | 638 | 0.250 |
Why?
|
Illusions | 1 | 2006 | 61 | 0.250 |
Why?
|
Evoked Potentials, Visual | 2 | 2009 | 417 | 0.250 |
Why?
|
Secondary Prevention | 1 | 2011 | 1469 | 0.250 |
Why?
|
Physician's Role | 1 | 2012 | 925 | 0.240 |
Why?
|
Problem Solving | 2 | 2007 | 442 | 0.240 |
Why?
|
Health Personnel | 1 | 2018 | 3384 | 0.240 |
Why?
|
Terminology as Topic | 2 | 2018 | 1540 | 0.230 |
Why?
|
Paired-Associate Learning | 1 | 2004 | 54 | 0.230 |
Why?
|
Models, Psychological | 1 | 2008 | 823 | 0.230 |
Why?
|
Discrimination Learning | 1 | 2006 | 276 | 0.230 |
Why?
|
Self Concept | 3 | 2015 | 1040 | 0.220 |
Why?
|
Veterans | 4 | 2024 | 2667 | 0.220 |
Why?
|
Aircraft | 1 | 2004 | 135 | 0.210 |
Why?
|
Floors and Floorcoverings | 1 | 2022 | 27 | 0.210 |
Why?
|
Executive Function | 5 | 2018 | 1396 | 0.210 |
Why?
|
Language | 3 | 2009 | 1550 | 0.200 |
Why?
|
Italy | 1 | 2024 | 856 | 0.200 |
Why?
|
Hypoxanthines | 1 | 2002 | 35 | 0.200 |
Why?
|
Single-Blind Method | 2 | 2024 | 1587 | 0.200 |
Why?
|
Life Change Events | 1 | 2007 | 956 | 0.200 |
Why?
|
Piperidines | 1 | 2011 | 1663 | 0.200 |
Why?
|
Adult | 38 | 2018 | 223307 | 0.190 |
Why?
|
Terrorism | 1 | 2004 | 211 | 0.180 |
Why?
|
CA2 Region, Hippocampal | 1 | 2021 | 20 | 0.180 |
Why?
|
Ethylene Glycols | 2 | 2023 | 196 | 0.180 |
Why?
|
Environment Design | 1 | 2022 | 174 | 0.180 |
Why?
|
Concept Formation | 1 | 2002 | 159 | 0.180 |
Why?
|
Boston | 2 | 2024 | 9346 | 0.180 |
Why?
|
Presenilin-1 | 3 | 2015 | 665 | 0.180 |
Why?
|
Adaptation, Psychological | 3 | 2009 | 2662 | 0.170 |
Why?
|
Neurosciences | 1 | 2005 | 384 | 0.170 |
Why?
|
Philosophy, Medical | 1 | 2000 | 78 | 0.170 |
Why?
|
Neurology | 2 | 2024 | 785 | 0.160 |
Why?
|
Bayes Theorem | 2 | 2024 | 2354 | 0.160 |
Why?
|
Brain Diseases | 1 | 2008 | 1552 | 0.160 |
Why?
|
Purines | 1 | 2002 | 615 | 0.150 |
Why?
|
Uncertainty | 1 | 2023 | 764 | 0.150 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2108 | 0.150 |
Why?
|
Psychomotor Performance | 8 | 2015 | 1885 | 0.150 |
Why?
|
CADASIL | 1 | 2018 | 83 | 0.150 |
Why?
|
Neurofilament Proteins | 1 | 2020 | 335 | 0.150 |
Why?
|
Acoustic Stimulation | 3 | 2012 | 1253 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2000 | 457 | 0.140 |
Why?
|
Aniline Compounds | 2 | 2023 | 1079 | 0.140 |
Why?
|
Health | 1 | 2000 | 397 | 0.140 |
Why?
|
Association Learning | 3 | 2010 | 219 | 0.130 |
Why?
|
Severity of Illness Index | 8 | 2014 | 15908 | 0.130 |
Why?
|
Anatomy | 1 | 2018 | 126 | 0.130 |
Why?
|
Apolipoprotein E4 | 3 | 2023 | 709 | 0.130 |
Why?
|
Psychometrics | 4 | 2018 | 3060 | 0.130 |
Why?
|
Education | 1 | 2018 | 531 | 0.130 |
Why?
|
Time Factors | 7 | 2018 | 40149 | 0.120 |
Why?
|
Sesquiterpenes | 1 | 1996 | 175 | 0.120 |
Why?
|
Age Factors | 6 | 2018 | 18397 | 0.120 |
Why?
|
Walking | 1 | 2022 | 1201 | 0.120 |
Why?
|
Cerebrovascular Disorders | 1 | 2022 | 1479 | 0.120 |
Why?
|
Fluorine Radioisotopes | 1 | 2018 | 405 | 0.120 |
Why?
|
Autopsy | 3 | 2023 | 1011 | 0.120 |
Why?
|
Peptide Fragments | 3 | 2024 | 5143 | 0.120 |
Why?
|
Intelligence Tests | 4 | 2014 | 504 | 0.120 |
Why?
|
Cerebral Cortex | 3 | 2007 | 5753 | 0.120 |
Why?
|
Association | 1 | 2014 | 53 | 0.110 |
Why?
|
E-Selectin | 1 | 1996 | 575 | 0.110 |
Why?
|
Entorhinal Cortex | 1 | 2015 | 285 | 0.110 |
Why?
|
Auditory Perception | 1 | 2018 | 586 | 0.110 |
Why?
|
Adolescent | 18 | 2017 | 88904 | 0.110 |
Why?
|
Minority Groups | 1 | 2021 | 1208 | 0.110 |
Why?
|
Education, Medical | 1 | 2005 | 1744 | 0.110 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9611 | 0.110 |
Why?
|
Signal Detection, Psychological | 2 | 2005 | 83 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2846 | 0.100 |
Why?
|
Electrophysiology | 2 | 2006 | 1263 | 0.100 |
Why?
|
Functional Laterality | 3 | 2010 | 2243 | 0.100 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1996 | 678 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1794 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 998 | 0.100 |
Why?
|
Curriculum | 2 | 2022 | 3783 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1659 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2015 | 606 | 0.100 |
Why?
|
Quisqualic Acid | 1 | 1991 | 35 | 0.100 |
Why?
|
South America | 1 | 2011 | 180 | 0.090 |
Why?
|
Behavioral Symptoms | 1 | 2013 | 188 | 0.090 |
Why?
|
Guanosine Diphosphate | 1 | 1991 | 79 | 0.090 |
Why?
|
Thionucleotides | 1 | 1991 | 107 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 10 | 2018 | 36567 | 0.090 |
Why?
|
Physical Fitness | 1 | 2015 | 743 | 0.090 |
Why?
|
Discriminant Analysis | 1 | 2011 | 222 | 0.090 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2012 | 205 | 0.090 |
Why?
|
Kainic Acid | 1 | 1991 | 203 | 0.090 |
Why?
|
Superior Colliculi | 1 | 1991 | 97 | 0.090 |
Why?
|
Communication | 1 | 2005 | 3905 | 0.090 |
Why?
|
N-Methylaspartate | 1 | 1991 | 231 | 0.090 |
Why?
|
Nerve Net | 2 | 2018 | 2307 | 0.090 |
Why?
|
Psychiatry | 1 | 2022 | 1715 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4670 | 0.080 |
Why?
|
Athletes | 3 | 2012 | 1161 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 1996 | 1368 | 0.080 |
Why?
|
Perceptual Distortion | 2 | 2009 | 36 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4252 | 0.080 |
Why?
|
Pharmacogenetics | 1 | 2013 | 682 | 0.080 |
Why?
|
Blast Injuries | 1 | 2012 | 318 | 0.080 |
Why?
|
Head Injuries, Closed | 1 | 2009 | 133 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2783 | 0.070 |
Why?
|
Pharmaceutical Preparations | 1 | 2016 | 1086 | 0.070 |
Why?
|
Caregivers | 1 | 2020 | 2303 | 0.070 |
Why?
|
Geriatric Assessment | 2 | 2006 | 1422 | 0.070 |
Why?
|
Politics | 1 | 2014 | 821 | 0.070 |
Why?
|
Exploratory Behavior | 2 | 2005 | 271 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1186 | 0.070 |
Why?
|
Brain Damage, Chronic | 1 | 2007 | 265 | 0.070 |
Why?
|
Globus Pallidus | 1 | 2007 | 247 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1394 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1514 | 0.060 |
Why?
|
Brain Ischemia | 1 | 1999 | 3001 | 0.060 |
Why?
|
Substantia Nigra | 1 | 2007 | 346 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2808 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2007 | 616 | 0.060 |
Why?
|
Psycholinguistics | 1 | 2005 | 79 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4087 | 0.060 |
Why?
|
Videotape Recording | 1 | 2007 | 333 | 0.060 |
Why?
|
Chromosome Aberrations | 1 | 2011 | 1776 | 0.060 |
Why?
|
Prefrontal Cortex | 2 | 2006 | 2224 | 0.060 |
Why?
|
Retinal Ganglion Cells | 1 | 1991 | 810 | 0.060 |
Why?
|
Verbal Behavior | 1 | 2006 | 328 | 0.060 |
Why?
|
Neurofibrillary Tangles | 2 | 2021 | 457 | 0.060 |
Why?
|
Young Adult | 7 | 2018 | 59939 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2014 | 2429 | 0.060 |
Why?
|
ROC Curve | 2 | 2012 | 3620 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8228 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8045 | 0.060 |
Why?
|
Task Performance and Analysis | 1 | 2008 | 771 | 0.060 |
Why?
|
Pandemics | 1 | 2024 | 8735 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4424 | 0.060 |
Why?
|
Gene Expression | 1 | 1996 | 7585 | 0.050 |
Why?
|
Neuropsychiatry | 1 | 2024 | 76 | 0.050 |
Why?
|
Linear Models | 3 | 2014 | 5874 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39309 | 0.050 |
Why?
|
Neurons | 2 | 2021 | 9515 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2016 | 3429 | 0.050 |
Why?
|
Military Personnel | 1 | 2012 | 1260 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3684 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20144 | 0.050 |
Why?
|
Family Health | 1 | 2007 | 1254 | 0.050 |
Why?
|
Threonine | 1 | 2022 | 272 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5943 | 0.050 |
Why?
|
Phonetics | 1 | 2003 | 206 | 0.050 |
Why?
|
New York City | 1 | 2004 | 736 | 0.050 |
Why?
|
Hippocampus | 2 | 2012 | 3776 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1994 | 591 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2021 | 171 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2009 | 6020 | 0.050 |
Why?
|
Disease Progression | 6 | 2020 | 13640 | 0.050 |
Why?
|
Neural Pathways | 2 | 2009 | 3079 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15416 | 0.040 |
Why?
|
Photography | 1 | 2003 | 536 | 0.040 |
Why?
|
Models, Neurological | 1 | 2008 | 1747 | 0.040 |
Why?
|
Oxygen | 2 | 2010 | 4251 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26310 | 0.040 |
Why?
|
Data Interpretation, Statistical | 2 | 2006 | 2693 | 0.040 |
Why?
|
Social Values | 1 | 2000 | 224 | 0.040 |
Why?
|
Intelligence | 1 | 2004 | 925 | 0.040 |
Why?
|
Orientation | 1 | 2000 | 314 | 0.040 |
Why?
|
Amygdala | 1 | 2006 | 1375 | 0.040 |
Why?
|
Prospective Studies | 2 | 2020 | 54871 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2003 | 968 | 0.040 |
Why?
|
Amyloid | 1 | 2023 | 849 | 0.040 |
Why?
|
Dementia, Vascular | 1 | 2018 | 126 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12985 | 0.040 |
Why?
|
Phosphorylation | 2 | 2022 | 8307 | 0.030 |
Why?
|
Genetic Variation | 1 | 2012 | 6612 | 0.030 |
Why?
|
Random Allocation | 1 | 2001 | 2394 | 0.030 |
Why?
|
Plaque, Amyloid | 1 | 2021 | 769 | 0.030 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2007 | 1481 | 0.030 |
Why?
|
Cyclohexanes | 1 | 1996 | 151 | 0.030 |
Why?
|
Patients | 1 | 2002 | 908 | 0.030 |
Why?
|
Adrenal Cortex | 1 | 1996 | 134 | 0.030 |
Why?
|
Brain Injuries | 1 | 2007 | 2053 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2016 | 12430 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 281 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 8926 | 0.030 |
Why?
|
Goals | 1 | 2000 | 717 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 65273 | 0.030 |
Why?
|
Disease | 1 | 2000 | 675 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 13036 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2018 | 751 | 0.030 |
Why?
|
P-Selectin | 1 | 1996 | 598 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1996 | 692 | 0.030 |
Why?
|
Anniversaries and Special Events | 1 | 2014 | 97 | 0.030 |
Why?
|
Capillaries | 1 | 1996 | 755 | 0.030 |
Why?
|
Mutation | 3 | 2015 | 30213 | 0.030 |
Why?
|
Mental Competency | 1 | 2014 | 179 | 0.030 |
Why?
|
Cohort Studies | 4 | 2024 | 41710 | 0.030 |
Why?
|
Trail Making Test | 1 | 2012 | 57 | 0.030 |
Why?
|
Postmortem Changes | 1 | 2012 | 119 | 0.020 |
Why?
|
Sex Factors | 1 | 2006 | 10619 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2017 | 81635 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 588 | 0.020 |
Why?
|
Acceleration | 1 | 2012 | 189 | 0.020 |
Why?
|
Angiogenesis Inducing Agents | 1 | 1993 | 254 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1285 | 0.020 |
Why?
|
Speech Perception | 1 | 2016 | 512 | 0.020 |
Why?
|
Cattle | 1 | 1996 | 3815 | 0.020 |
Why?
|
Long-Term Potentiation | 1 | 2012 | 289 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14762 | 0.020 |
Why?
|
Psychoacoustics | 1 | 2010 | 59 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2013 | 810 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1996 | 1612 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2012 | 323 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2418 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Reality Testing | 1 | 2009 | 23 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 8066 | 0.020 |
Why?
|
Names | 1 | 2009 | 54 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2093 | 0.020 |
Why?
|
Pilot Projects | 1 | 2002 | 8728 | 0.020 |
Why?
|
Social Behavior | 1 | 2015 | 1147 | 0.020 |
Why?
|
Animals | 5 | 2012 | 168930 | 0.020 |
Why?
|
Famous Persons | 1 | 2009 | 109 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2795 | 0.020 |
Why?
|
Child | 2 | 2006 | 80668 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4018 | 0.020 |
Why?
|
Exercise Test | 1 | 2015 | 2188 | 0.020 |
Why?
|
Age of Onset | 1 | 2015 | 3342 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2013 | 1459 | 0.020 |
Why?
|
Football | 1 | 2012 | 504 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3432 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4114 | 0.020 |
Why?
|
Head | 1 | 2012 | 926 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21525 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1175 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5887 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2009 | 951 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2007 | 9101 | 0.020 |
Why?
|
Individuality | 1 | 2007 | 303 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2007 | 595 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2012 | 1865 | 0.010 |
Why?
|
Visual Cortex | 1 | 2012 | 1081 | 0.010 |
Why?
|
Axons | 1 | 2012 | 1675 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1676 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 1994 | 2631 | 0.010 |
Why?
|
Alzheimer Vaccines | 1 | 2003 | 25 | 0.010 |
Why?
|
Sports | 1 | 2009 | 701 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2351 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1996 | 7609 | 0.010 |
Why?
|
Epitope Mapping | 1 | 2003 | 301 | 0.010 |
Why?
|
United States | 2 | 2024 | 72951 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3450 | 0.010 |
Why?
|
Mental Processes | 1 | 2003 | 242 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1996 | 12791 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2012 | 2678 | 0.010 |
Why?
|
Brain Concussion | 1 | 2012 | 1431 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1993 | 2184 | 0.010 |
Why?
|
Sleep | 1 | 2016 | 4815 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3321 | 0.010 |
Why?
|
Autoantigens | 1 | 2003 | 886 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2003 | 1742 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1986 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13278 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3531 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2003 | 1560 | 0.010 |
Why?
|
Stroke | 1 | 2018 | 9741 | 0.010 |
Why?
|
Educational Status | 1 | 2004 | 2510 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5923 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15831 | 0.010 |
Why?
|
Rats | 1 | 1991 | 23717 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6012 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18330 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12806 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16044 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1994 | 1697 | 0.010 |
Why?
|
Cytokines | 1 | 2003 | 7438 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 18075 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2003 | 10264 | 0.000 |
Why?
|
Risk Factors | 1 | 2013 | 74881 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81889 | 0.000 |
Why?
|
Neoplasms | 1 | 1994 | 22350 | 0.000 |
Why?
|
Survival Analysis | 1 | 1994 | 10100 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 1994 | 12534 | 0.000 |
Why?
|
Prognosis | 1 | 1994 | 29948 | 0.000 |
Why?
|